Biblio
Lessons learned from SMAD4 loss in squamous cell carcinomas. Mol Carcinog. 2019.
. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. Proc Natl Acad Sci U S A. 2013.